Ep. 131: “Lymphocyte Development” Featuring Dr. Alfred Singer
From The Immunology Podcast · · 1 hr 10 min
This plays from the publisher's own server. We do not host a copy.
Description
Guest:
Dr. Alfred Singer is a Senior Investigator at the National Cancer Institute Center for Cancer Research. He discusses his pioneering work on thymus development and T cell differentiation, including how T cells are selected to become CD4 helper or CD8 cytotoxic cells through MHC-restricted signaling. He shares the evolution of key concepts in the field, such as the “kinetic signaling” model of lineage commitment, and offers insights into T cell receptor signaling, regulatory T cell development, and the complexities of immune cell fate decisions.
Featured Products and Resources:
- Receive a free 250 mL bottle of Lymphoprep plus a free SepMate tube to try in your own lab. (http://www.stemcell.com/sample-sepmate-lymphoprep)
- Achieve simple, reliable EV isolation with EasySep kits from STEMCELL Technologies. (https://www.stemcell.com/t-cell-therapy?utm_source=impodcast&utm_medium=banner)
The Immunology Science Round Up
CEACAM6 Enables Viral Entry (https://www.nature.com/articles/s41586-026-10394-x) – Bat alphacoronavirus enters human cells via CEACAM6, revealing potential for zoonotic transmission.
Cross-Dressing Drives T Cell Priming (https://www.nature.com/articles/s41586-026-10353-6) – mRNA vaccines activate CD8+ T cells through redundant dendritic cell pathways and cross-dressing mechanisms.
Unlocking NK Antitumor Responses (https://www.science.org/doi/10.1126/sciimmunol.adx4411) – Removing tumor Tregs unleashes NK cell responses to control cancers, including MHC I–deficient tumors.
RUNX1 Controls Immune Aging (https://www.cell.com/immunity/abstract/S1074-7613%2826%2900077-4) – A single-cell immune aging clock identifies RUNX1 as a key regulator of T cell senescence and rejuvenation.
Image courtesy of Dr. Alfred Singer
Subscribe to our newsletter!
Never miss updates about new episodes.
Subscribe